Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
358 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06246630 | In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor | unknown | N/A | 20 | Ruijin HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06404697 | Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients | recruiting | Phase 2 | 24 | Ruijin HospitalOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06256224 |
| Toripalimab Combined With Definitive CCRT for LACC Patients |
| recruiting |
| N/A |
| 150 |
| Ruijin HospitalOTHER |
| 1 |
| Apr 24, 2024 |
| clinicaltrials |
| NCT06364852 | An Evaluation of LY007 Cell Injection for r/r B-NHL(r/r B-NHL) | unknown | Phase 1 | 18 | Ruijin HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06363084 | A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer | completed | — | 64 | Ruijin HospitalOTHER | 0 | Apr 12, 2024 | clinicaltrials |
| NCT06231186 | a Feasibility Study of iHD-SRT for BM | recruiting | N/A | 35 | Ruijin HospitalOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT06329999 | A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML | recruiting | N/A | 78 | Ruijin HospitalOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06255795 | The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma | not yet recruiting | Phase 3 | 142 | Ruijin HospitalOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT04994197 | Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS | unknown | — | 970 | Ruijin HospitalOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT05140746 | Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer | recruiting | N/A | 40 | Ruijin HospitalOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT05675813 | Genotype-guided Treatment in Newly Diagnosed PTCL(THEORY) | recruiting | Phase 1 / Phase 2 | 264 | Ruijin HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT06185907 | In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors(GGC-01) | completed | — | 3,238 | Ruijin HospitalOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT06181942 | A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological Surgeries(SPiM-RWS-URO) | unknown | — | 15 | Ruijin HospitalOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT05401045 | Effect of a Self-designed MET Exercise Intervention on Cancer-related Fatigue in Patients With Gastric Cancer(SMEE) | completed | N/A | 119 | Ruijin HospitalOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT05501990 | Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients | unknown | N/A | 800 | Ruijin HospitalOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT06177561 | Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT | unknown | N/A | 38 | Ruijin HospitalOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT05262335 | Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001)(ALTER-G-001) | unknown | Phase 2 | 116 | Ruijin HospitalOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT06146985 | Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer | unknown | Phase 2 | 67 | Ruijin HospitalOTHER | 0 | Nov 28, 2023 | clinicaltrials |
| NCT06122493 | Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma | recruiting | Phase 2 | 48 | Ruijin HospitalOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT06062641 | Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL | not yet recruiting | Phase 2 | 50 | Ruijin HospitalOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06114225 | Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial(PROMIS) | recruiting | Phase 2 | 43 | Ruijin HospitalOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT03742193 | Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy(PROACH) | unknown | Phase 2 | 43 | Ruijin HospitalOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT03134534 | Robot-assisted vs VATS Lobectomy for NSCLC(RVlob) | completed | N/A | 320 | Ruijin HospitalOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT06074692 | PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)(PRIMA) | recruiting | Phase 2 | 86 | Ruijin HospitalOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT05916261 | Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer | recruiting | Early Phase 1 | 54 | Ruijin HospitalOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT05923502 | (CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL) | not yet recruiting | — | 200 | Ruijin HospitalOTHER | 0 | Oct 23, 2023 | clinicaltrials |
| NCT04115527 | Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma. | unknown | N/A | 100 | Ruijin HospitalOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT06054984 | TCR-T Cells in the Treatment of Advanced Pancreatic Cancer(GB3010-02) | unknown | Early Phase 1 | 18 | Ruijin HospitalOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT03108677 | Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma | unknown | — | 90 | Ruijin HospitalOTHER | 1 | Oct 3, 2023 | clinicaltrials |
| NCT06049381 | Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research | unknown | — | 22 | Ruijin HospitalOTHER | 0 | Sep 22, 2023 | clinicaltrials |
| NCT05896007 | Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT | unknown | Phase 2 | 29 | Ruijin HospitalOTHER | 1 | Sep 5, 2023 | clinicaltrials |
| NCT05926427 | Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement | unknown | Phase 2 | 25 | Ruijin HospitalOTHER | 1 | Sep 5, 2023 | clinicaltrials |
| NCT05976412 | Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer | recruiting | N/A | 1,355 | Ruijin HospitalOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT05871684 | A Combination Study of CAR-T Therapy in r/r B-NHL | unknown | Phase 2 | 48 | Ruijin HospitalOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05923879 | Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma | unknown | — | 30 | Ruijin HospitalOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT05907447 | A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types | unknown | — | 10,000 | Ruijin HospitalOTHER | 1 | Jun 18, 2023 | clinicaltrials |
| NCT03809247 | Microbial Diversity of Pancreatic Diseases | unknown | — | 330 | Ruijin HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05193162 | Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases | unknown | — | 800 | Ruijin HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT04480099 | Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma | unknown | Phase 2 | 96 | Ruijin HospitalOTHER | 1 | Jun 13, 2023 | clinicaltrials |
| NCT05899621 | A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL | recruiting | — | 332 | Ruijin HospitalOTHER | 1 | Jun 12, 2023 | clinicaltrials |
| NCT05179733 | The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years | unknown | Phase 3 | 280 | Ruijin HospitalOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT05870969 | Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)(dSEARCH) | recruiting | — | 20,000 | Ruijin HospitalOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT05863845 | Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL | unknown | N/A | 52 | Ruijin HospitalOTHER | 0 | May 18, 2023 | clinicaltrials |
| NCT05863871 | Real World Study of Linperlisib for Lymphoma Treatment(MA-LYM-RWS-001) | not yet recruiting | — | 1,000 | Ruijin HospitalOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05749211 | Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer | unknown | N/A | 59 | Ruijin HospitalOTHER | 0 | May 16, 2023 | clinicaltrials |
| NCT05852028 | A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma | unknown | — | 250 | Ruijin HospitalOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05556603 | AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC) | recruiting | — | 7,062 | Ruijin HospitalOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05822726 | The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate Cancer | unknown | N/A | 240 | Ruijin HospitalOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05800067 | Axi-cel Retreatment in Relapsed/Refractory LBCL | unknown | N/A | 32 | Ruijin HospitalOTHER | 1 | Apr 5, 2023 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials